Follow-The-Filings

AIDX 20/20 Biolabs

20/20 Biolabs earnings company data as of 7:03 AM ET 8/20

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

History

1 period · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2026 Q2 14 Aug EPS
Rev $700.0K

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.07
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
8-K 2.02,9.01
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
10-Q QUARTERLY REPORT
8-K 7.01,9.01
8-K 1.01,3.01,9.01
8-K 7.01,9.01
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
8-K 3.03,5.03,9.01
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
8-K 2.02,9.01
10-Q QUARTERLY REPORT
8-K 1.01,9.01
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS
424B3 PROSPECTUS
S-1 REGISTRATION STATEMENT
8-K 2.02,9.01
10-K ANNUAL REPORT
424B3 PROSPECTUS
S-1/A AMENDMENT NO. 2 TO FORM S-1

Insider forms

Form 3 / 4 / 5 from EDGAR · 5 of 7 shown

Filed Form Detail Links
4 Period Apr 2, 2026
4 Period Apr 2, 2026
4 Period Mar 3, 2026
4 Period Feb 19, 2026
4 Period Feb 19, 2026

2 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice